Orbimed Advisors LLC Agilent Technologies, Inc. Transaction History

Orbimed Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$65.59 - $78.07 $58.6 Million - $69.7 Million	-893,200 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$66.89 - $81.94 $6.32 Million - $7.74 Million	94,500 Added 11.83%	893,200 $66.7 Million
Q1 2019 May 15, 2019	BUY	$63.27 - $82.0 $2.89 Million - $3.75 Million	45,700 Added 6.07%	798,700 $64.2 Million
Q4 2018 Feb 14, 2019	SELL	$61.13 - $74.67 $20.3 Million - $24.8 Million	-332,100 Reduced 30.61%	753,000 $50.8 Million
Q3 2018 Nov 14, 2018	SELL	$61.25 - $71.13 $49 Million - $56.9 Million	-800,000 Reduced 42.44%	1,085,100 $76.5 Million
Q2 2018 Aug 14, 2018	SELL	$61.14 - $69.55 $58.2 Million - $66.2 Million	-951,800 Reduced 33.55%	1,885,100 $117 Million
Q1 2018 May 15, 2018	BUY	$65.05 - $74.82 $16 Million - $18.4 Million	246,200 Added 9.5%	2,836,900 $190 Million
Q4 2017 Feb 14, 2018	SELL	$64.87 - $70.59 $68 Million - $74 Million	-1,048,200 Reduced 28.81%	2,590,700 $173 Million
Q3 2017 Nov 14, 2017	BUY	$58.57 - $66.17 $213 Million - $241 Million	3,638,900	3,638,900 $234 Million

1,148

252M

729K

970K

Ticker A
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 296,040,992
Market Cap $39.4B
Description
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatogra...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.